Sat, Apr 19, 2014, 7:39 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

GTX Inc. Message Board

littlejimmyvalentino 11 posts  |  Last Activity: Apr 14, 2014 10:15 PM Member since: Apr 27, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • littlejimmyvalentino by littlejimmyvalentino Apr 14, 2014 10:15 PM Flag

    On February 6, 2012, the Company entered into a letter agreement (the “Schuler Agreement”) with Jack W.
    Going concern issues? Really? C'mon. Let's be real shall we?

    1. Jack Schuler controls 14% of the company. He's allowed to own 19.99%. (See below for SEC Filing)

    2. He recruited a rock star of a CEO who can make himself a very, wealthy man if he's able to execute his business plan. As of now, he's basically been working for free.

    3. What has likely transpired? It's no secret that they were going to have to financing. The shelf was filed long ago. The deal might be taking longer than they like. What was the auditor to do? They had to slap them with a "going concern" qualification. (For example: What if Schuler became incapacitated and his foundation/family lost interest?)

    4. Unfortunately, the market turned just when they needed to turn on the spigot. But to think that going concerns are real strains the boundaries of commons sense given who the largest shareholder and who was hired

    Schuler, Renate Schuler and the Schuler Family Foundation, a tax-exempt private operating foundation of which Jack W. Schuler and Renate Schuler serve as two of the three directors (collectively, the “Schuler Stockholders”). The Schuler Stockholders may be deemed to have aggregate beneficial ownership of up to 5,091,295 shares, or approximately 14.7%, of the Company’s outstanding common stock.

    Pursuant to the Schuler Agreement, the Schuler Stockholders have made certain representations and covenants regarding ownership, voting support arrangements, standstill arrangements and rights of first refusal. In exchange for these representations and covenants, the Company agreed to amend the Shareholder Rights Plan to allow the Schuler Stockholders, under certain circumstances, to increase their beneficial ownership up to 19.99% of the outstanding common stock without becoming Acquiring Persons (as defined in the Rights Agreemen

  • Reply to

    What happened to May? They lied.

    by michaelhensen35 Apr 8, 2014 9:28 AM
    littlejimmyvalentino littlejimmyvalentino Apr 9, 2014 10:08 PM Flag

    Westernreader is correct. I shouldn't call people names. To be diplomatic Mr. Hensen, your knowledge and reasoning is lacking.

  • Reply to

    What happened to May? They lied.

    by michaelhensen35 Apr 8, 2014 9:28 AM
    littlejimmyvalentino littlejimmyvalentino Apr 8, 2014 12:53 PM Flag

    You are an absolute idiot. Anytime Schuler buys or sells stock he has to file an amended 13-D or 13 -G. Schuler has NEVER sold a share.

  • littlejimmyvalentino by littlejimmyvalentino Mar 28, 2014 9:27 AM Flag

    As part of the shelf, Schuler is permitted to increase his holdings to 19.9%. Does anybody really think that he is "out of the loop". Give me a break.

    You'd have to be insane to short this stock.

  • Reply to

    Sorry Longs. Stock price going down.

    by ilovepelosi Mar 27, 2014 9:53 PM
    littlejimmyvalentino littlejimmyvalentino Mar 28, 2014 7:45 AM Flag

    Hard to believe that this was a surprise to anyone given that the shelf was filed several weeks ago. We'll see who is right on this. I predict that the stock barely moves.

  • littlejimmyvalentino by littlejimmyvalentino Mar 27, 2014 6:32 PM Flag

    What on earth were people expecting? Three dollars or forty cents based upon this earnings release? How ludicrous. I could have written this thing two months ago and I would have gotten about 85% of it correct.

    Who's surprised that they need a capital raise? They filed a shelf for $50MM shortly after the first of the year. So the fact that they have to raise that amount should not be a surprise.

    Who's surprised that the new CEO is ambitious and wants to build a new plant to facilitate the manufacturer of their new products? That shouldn't be a surprise.

    Who's surprised that they lost a bunch of money?

    The big question to me is not what was announced today. The big question is how are they going to get that $50MM? Will Shaulson pony up big bucks for more stock? Will Schuler increase his holdings to 19.9%? Or will they both take a back seat....

    That's what we have to find out. Today's press release was a yawner and totally expected. My prediction is the stock doesn't budge one way or another.

  • littlejimmyvalentino by littlejimmyvalentino Mar 18, 2014 10:50 PM Flag

    Yahoo Finance is not the final answer. SEC's Edgar system is. There have been no MBLX filings since February. Schuler's involvement remains intact. Yahoo might be confusing his personal holdings vis a vis his foudnation's.

  • Reply to

    I bought at $67.28!

    by tybinger765 Mar 6, 2014 1:39 PM
    littlejimmyvalentino littlejimmyvalentino Mar 6, 2014 5:39 PM Flag

    Even worse...You can't spell catalyst. Xtandi is the whole ball of wax. Most believe that they were conservative on their guidance--but the guidance was less than what was hoped for. Urologists have a strong incentive to prescribe Xtandi---I'm in

  • Reply to

    People are finally holding their shares

    by floydtrainer Feb 27, 2014 11:02 AM
    littlejimmyvalentino littlejimmyvalentino Feb 27, 2014 9:58 PM Flag

    Indeed...Dah is correct here. Marckx of Zacks is the only analyst covering this and he bases all of his valuation models based upon fully diluted shares. Presently the market cap is what Dah says that it is.

  • littlejimmyvalentino by littlejimmyvalentino Feb 24, 2014 10:33 PM Flag

    First of all...Most corporate public relations departments are NOT 24 hour operations. The Orphan Drug Designation came out well after the stock market closed and in all likelihood after the company's public relations department or agency was home for the day. The FDA's granting of Orphan Drug status is documented and it will undoubtedly propel the stock.

    Keep in mind that the news today was considered a "long shot" and the news came completely out of left field. The share count isn't as easy to calculate as going on Yahoo's statistic pages because their recent financing put in place a bunch of warrants that will be available at a price far less than tomorrow's stock price. (I can't even imaging the IRR that these warrant holders got....)

    The big question is, "How high will the stock go?" Let's assume that DARA has 10MM fully diluted shares after the warrants are exercised. So let's say before the news we were talking about at $25MM company. Is the Orphan status alone worth the price of the company prior to the news? It might very well be.

    Make no mistake about it--this was huge news--those who are claiming that it's no big deal and just like ZLCS are in one word, "wrong". We'll see who they license up with--and we can speculate all we want about how much it will go up--but I would not be surprised if we see an ICPT percentage type move (though nothing like the overall market cap of ICPT).

  • littlejimmyvalentino by littlejimmyvalentino Feb 24, 2014 7:47 PM Flag

    I have the the posts made since the market closed and am amazed that not a single person posted the reason for the after hours activity--simply put, KRN5500 received Orphan Drug Designation from the FDA. This was considered to be a long shot and the news came surprisingly early.

1.32-0.04(-2.94%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.